Close Menu
Innovation Village | Technology, Product Reviews, Business
    Facebook X (Twitter) Instagram
    Monday, June 16
    • About us
      • Authors
    • Contact us
    • Privacy policy
    • Terms of use
    • Advertise
    • Newsletter
    • Post a Job
    • Partners
    Facebook X (Twitter) LinkedIn YouTube WhatsApp
    Innovation Village | Technology, Product Reviews, Business
    • Home
    • Innovation
      • Products
      • Technology
      • Internet of Things
    • Business
      • Agritech
      • Fintech
      • Healthtech
      • Investments
        • Cryptocurrency
      • People
      • Startups
      • Women In Tech
    • Media
      • Entertainment
      • Gaming
    • Reviews
      • Gadgets
      • Apps
      • How To
    • Giveaways
    • Jobs
    Innovation Village | Technology, Product Reviews, Business
    You are at:Home»Health»partnership enables launch of COVID-19 immunity test
    antibodies covid-19 immunity test

    partnership enables launch of COVID-19 immunity test

    0
    By Tajudeen Adegbenro on October 13, 2021 Health, Healthtech

    Luas Diagnostics launched an enhanced test to determine immunity to covid-19 post-vaccination or infection. The upgraded offering follows the development of a smartphone app and data management software that is specific to the Luas product, by Bond Digital Health.

    Chembio Diagnostics Systems of New York manufactured the immunity test. It makes use of fingerstick of blood for detection, differentiation, and qualification of IgG and IgM receptor binding domain antibodies to SARS-CoV-2. The results are read and stored in a portable reader that provides semi-quantitative results in either remote or laboratory settings. It takes 15 minutes to get the results.

    The Luas Diagnostics app is available on the Google Play Store and the Apple App Store.

    Both are powered by Transform, a lateral flow data capture platform developed by Bond Digital Health. The smartphone app provides a personalized shareable and printable antibody report and a linked dashboard that manages testing, reporting, and recording of results in real-time at single or multiple locations.

    The CEO of Luas Diagnostics, Brendan Farrell said: “We are glad to work together with Bond Digital Health to provide a comprehensive Immunity Test offering with applications in many locations which includes workplace, care homes, in-store testing, and GP surgeries. A recent study reveals that 10-15% specifically among the higher age group, may not produce antibodies even after taking the second dosage of the vaccine and may have limited protection against the virus. This brings about the need for individuals to have the understanding of their immunity status with regular testing.”

    Ian Smith, CEO of Bond Digital Health, added: “Antibody testing is the next tool we should be using in the fight against COVID-19. That’s why we are proud to partner with Luas on their vital Immunity Test. But testing alone isn’t enough. Whether in workplaces, care homes, GP surgeries, or in the community, we need to capture the test data, store it securely and share it to make sure we have a complete picture of immunity. The Luas App, powered by Transform, does just that.” 

    Related

    covid-19 immunity test covid-19 test
    Share. Facebook Twitter Pinterest LinkedIn Email
    Tajudeen Adegbenro

    Passion for truly awesome engaging content

    Related Posts

    IFC Invests $10m in KERA Health to Power AI-Led Healthcare Reform in West Africa

    Neuralink Raises $650M at $9B Valuation to Advance Brain-Computer Interface Technology

    Gates Foundation Awards $5m Grant to Axmed to Boost Access to Lifesaving Medicines in Africa

    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    Copyright ©, 2013-2024 Innovation-Village.com. All Rights Reserved

    Type above and press Enter to search. Press Esc to cancel.